Table 1. Subject Characteristics.
N (%) | |
---|---|
Modified intent to treat population | 62 |
Median age, years (range) | 39 (20-60) |
Sex M/F | 41/21 |
Stem cell source | |
bone marrow | 30 (48) |
peripheral blood | 31 (52) |
Donor | |
6/6 matched related donor | 30 (48) |
5/6 matched related donor | 1 (2) |
6/6 matched unrelated donor | 31 (50) |
Diagnosis | |
AML | 19 (31) |
ALL | 14 (23) |
CML | 15 (24) |
NHL | 5 (8) |
MDS | 3 (5) |
CLL | 3 (5) |
Other | 3 (5) |
Disease Status at transplant | |
CR 1 | 26 (42) |
After 1st or 2nd Relapse | 29 (47) |
Primary Refractory | 7 (11) |
AML indicates acute myeloid leukemia; ALL, acute lymphoblastic leukemia; CML, chronic myeloid leukemia; NHL, non-hodgkins lymphoma; MDS, myelodysplastic syndrome; CLL, chronic lymphocytic leukemia.